FPH Director Geraldine McBride to retire
News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)
Fisher & Paykel Healthcare Director Geraldine McBride to retire
Auckland, New Zealand, 6 July 2022 - Fisher & Paykel Healthcare Director Geraldine McBride
has announced her intention to retire from the board with effect from the close of the company’s
Annual Shareholders’ Meeting in August this year.
Ms McBride has served as an independent director on the board at Fisher & Paykel Healthcare
since August 2013, and Board Chair Scott St John commends the contribution she has made in
the years since.
“Geraldine has been a valuable presence in the boardroom throughout a period of significant
growth for our company,” said Mr St John. “We have benefitted greatly from her experience,
drawn from a successful career working with some of the world’s largest technology players.
Her intentions were first signalled to the Board earlier this year, and they are in line with our
succession process.”
This announcement follows the appointment of Cather Simpson to the board as an independent
director, effective 1 June.
“With Cather now underway ahead of Geraldine’s departure, we consider the board to be at full
strength,” said Mr St John. “We are looking forward to formally introducing Cather and
acknowledging Geraldine’s contribution at our upcoming Annual Shareholders’ Meeting.”
The annual shareholders’ meeting will be held online at www.virtualmeeting.co.nz/FPH22 and in
person at the Guineas Ballroom, Ellerslie Event Centre, Auckland, New Zealand on
Wednesday, 24 August 2022 commencing at 2.00pm (NZST).
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and
systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive
sleep apnea. The company’s products are sold in over 120 countries worldwide. For more
information about the company, visit our website www.fphcare.com.
Media & Investor Contacts:
Karen Knott
GM Corporate Communications
karen.knott@fphcare.co.nz
+64 21 713 911
Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 27 807 8073
Authorised by Fisher & Paykel Healthcare Corporation Limited’s Company Secretary.
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- TWR — Tower Limited: Appointment of Geraldine McBride to Tower Board2022-09-28
“Level 5, 136 Fanshawe Street Auckland 1142, New Zealand ARBN 645 941 028 Incorporated in New Zealand Classification: Highly Sensitive Market Information NZX Limited Level 1, NZX Centre 11 Cable Street Wellington New Zealand Company Announcements Office ASX…”
- PHL — Promisia Healthcare Limited: Board Changes2022-08-18
“Market Announcement 18 August 2022 15311792_1 BOARD CHANGES DIRECTOR RETIREMENT Promisia Healthcare Limited (NZX:PHL) advises that with effect from the conclusion of the annual shareholders’ meeting this Friday 19 August 2022, Andrew Mitchell will retire as a director o…”
- PHL — Promisia Healthcare Limited: Resignation of CEO2022-04-20
“14697448_1 NZX MARKET ANNOUNCEMENT 20 April 2022 CEO RESIGNATION Promisia Healthcare Limited (NZX:PHL) advises that Chris Brown has resigned as the CEO of PHL and will finish with the company on Friday, 22 April 2022. Chris has been with the company just over a year, init…”